BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34004450)

  • 1. Towards a comprehensive characterisation of the human internal chemical exposome: Challenges and perspectives.
    David A; Chaker J; Price EJ; Bessonneau V; Chetwynd AJ; Vitale CM; Klánová J; Walker DI; Antignac JP; Barouki R; Miller GW
    Environ Int; 2021 Nov; 156():106630. PubMed ID: 34004450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application of multiomics mass spectrometry in the research of chemical exposome].
    Song YY; Qi ZH; Cai ZW
    Se Pu; 2024 Feb; 42(2):120-130. PubMed ID: 38374592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical strategies to profile the internal chemical exposome and the metabolome of human placenta.
    Al-Salhi R; Monfort C; Bonvallot N; David A
    Anal Chim Acta; 2022 Aug; 1219():339983. PubMed ID: 35715127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemical exposome and non-targeted approaches].
    David A; Chaker J; Multigner L; Bessonneau V
    Med Sci (Paris); 2021 Oct; 37(10):895-901. PubMed ID: 34647878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the sensitivity of a low- and a high-resolution mass spectrometry approach for xenobiotic trace analysis: An exposome-type case study.
    Flasch M; Koellensperger G; Warth B
    Anal Chim Acta; 2023 Oct; 1279():341740. PubMed ID: 37827628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-targeted analysis (NTA) and suspect screening analysis (SSA): a review of examining the chemical exposome.
    Manz KE; Feerick A; Braun JM; Feng YL; Hall A; Koelmel J; Manzano C; Newton SR; Pennell KD; Place BJ; Godri Pollitt KJ; Prasse C; Young JA
    J Expo Sci Environ Epidemiol; 2023 Jul; 33(4):524-536. PubMed ID: 37380877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blurred lines: Crossing the boundaries between the chemical exposome and the metabolome.
    Balcells C; Xu Y; Gil-Solsona R; Maitre L; Gago-Ferrero P; Keun HC
    Curr Opin Chem Biol; 2024 Feb; 78():102407. PubMed ID: 38086287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring long-term chemical exposome by characterizing the hair metabolome using a high-resolution mass spectrometry-based suspect screening approach.
    Chang CW; Hsu JY; Su YH; Chen YC; Hsiao PZ; Liao PC
    Chemosphere; 2023 Aug; 332():138864. PubMed ID: 37156292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the chemical exposome in cohort studies: routes explored and steps to become comprehensive.
    Huhn S; Escher BI; Krauss M; Scholz S; Hackermüller J; Altenburger R
    Environ Sci Eur; 2021; 33(1):17. PubMed ID: 33614387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in the application of high-resolution mass spectrometry for human biomonitoring: An analytical primer to studying the environmental chemical space of the human exposome.
    Andra SS; Austin C; Patel D; Dolios G; Awawda M; Arora M
    Environ Int; 2017 Mar; 100():32-61. PubMed ID: 28062070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An annotation database for chemicals of emerging concern in exposome research.
    Meijer J; Lamoree M; Hamers T; Antignac JP; Hutinet S; Debrauwer L; Covaci A; Huber C; Krauss M; Walker DI; Schymanski EL; Vermeulen R; Vlaanderen J
    Environ Int; 2021 Jul; 152():106511. PubMed ID: 33773387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connecting chemical exposome to human health using high-resolution mass spectrometry-based biomonitoring: Recent advances and future perspectives.
    Chen YC; Hsu JF; Chang CW; Li SW; Yang YC; Chao MR; Chen HC; Liao PC
    Mass Spectrom Rev; 2023; 42(6):2466-2486. PubMed ID: 36062854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Critical Review on the Opportunity to Use Placenta and Innovative Biomonitoring Methods to Characterize the Prenatal Chemical Exposome.
    Contini T; Béranger R; Multigner L; Klánová J; Price EJ; David A
    Environ Sci Technol; 2023 Oct; 57(41):15301-15313. PubMed ID: 37796725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical challenges in human exposome analysis with focus on environmental analysis combined with metabolomics.
    Hyötyläinen T
    J Sep Sci; 2021 Apr; 44(8):1769-1787. PubMed ID: 33650238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference Standardization for Mass Spectrometry and High-resolution Metabolomics Applications to Exposome Research.
    Go YM; Walker DI; Liang Y; Uppal K; Soltow QA; Tran V; Strobel F; Quyyumi AA; Ziegler TR; Pennell KD; Miller GW; Jones DP
    Toxicol Sci; 2015 Dec; 148(2):531-43. PubMed ID: 26358001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scannotation: A Suspect Screening Tool for the Rapid Pre-Annotation of the Human LC-HRMS-Based Chemical Exposome.
    Chaker J; Gilles E; Monfort C; Chevrier C; Lennon S; David A
    Environ Sci Technol; 2023 Dec; 57(48):19253-19262. PubMed ID: 37968235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing a Biology-Driven Approach to Map the Exposome in Health and Disease: An Essential Investment to Drive the Next Generation of Environmental Discovery.
    Chung MK; Rappaport SM; Wheelock CE; Nguyen VK; van der Meer TP; Miller GW; Vermeulen R; Patel CJ
    Environ Health Perspect; 2021 Aug; 129(8):85001. PubMed ID: 34435882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk analysis of serum chemical residues for metabolic associated fatty liver disease based on exposome-lipidome wide association study].
    Chen QQ; You L; Guan PW; Fang CN; Qin WS; Liu XY; Xu GW
    Se Pu; 2024 Feb; 42(2):164-175. PubMed ID: 38374597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tooth biomarkers to characterize the temporal dynamics of the fetal and early-life exposome.
    Yu M; Tu P; Dolios G; Dassanayake PS; Volk H; Newschaffer C; Fallin MD; Croen L; Lyall K; Schmidt R; Hertz-Piccioto I; Austin C; Arora M; Petrick LM
    Environ Int; 2021 Dec; 157():106849. PubMed ID: 34482270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of a comprehensive workflow for suspect screening of exposome-related xenobiotics and phase II metabolites in diverse human biofluids.
    Musatadi M; Baciero-Hernández I; Prieto A; Olivares M; Etxebarria N; Zuloaga O
    Chemosphere; 2024 Mar; 351():141221. PubMed ID: 38224745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.